Purchase Order 75N91019P00751
Award Date 9/21/19
Potential Completion Date 3/20/22
Potential Value $120K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20016, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute (NCI), an agency within the Department of Health and Human Services, awarded a $76,500 firm fixed price purchase order to Cancer Letter Inc. to provide an annual institution-wide online subscription to cancer research and drug development content through The Cancer Letter publication. The contract covers a 12-month period from September 21, 2018 to September 20, 2019, with access for 3,000-4,000 users. The subscription includes weekly updates on cancer-related...
- The National Cancer Institute, an agency of the Department of Health and Human Services, awarded a firm fixed price purchase order to Cancer Letter Inc. for an annual institution-wide subscription to The Cancer Letter publication. The $300,000 contract has a base period of performance from March 21, 2022 to March 20, 2023, with options to extend the subscription through March 20, 2027. The Cancer Letter is a weekly online publication covering cancer research, drug development, and health policy....
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,000 firm fixed price purchase order to Caerus US 1 Inc. for SOFTWARE. The place of performance is New York, NY. The one year contract starts on July 26, 2023 and ends on July 25, 2024. No set aside designation or subcontractors were identified. The National Cancer Institute is a part of NIH focused on cancer research, so this contract is likely to deliver software products or...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $11,690 firm fixed price purchase order to Springer Nature Customer Service Center LLC. Under this contract, Springer Nature will publish a scientific manuscript submitted to the journal Nature Cancer. The manuscript, titled "MANUSCRIPT: #NATCANCERA05718B," was reviewed and accepted for publication based on its relevance to the unique focus of the journal. Performance will take...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a one-year, firm fixed price purchase order valued at fourteen thousand four hundred ninety dollars to Certara USA Inc. for software licenses. Certara will provide the licenses to the NIH NCI in support of its mission to conduct and coordinate research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer,...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...
- Springer Nature Customer Service Center LLC has been awarded an $11,690 purchase order contract by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to provide manuscript publication services. The firm fixed price contract runs from June 2023 through June 2024 and will be performed in Bowling Green, New York. No major subcontractors or set aside designations were indicated. The National Cancer Institute is the federal agency responsible for...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,922 firm fixed price purchase order to Baylor College of Medicine for testing services. The contract has a period of performance from November 8, 2023 through January 8, 2024 and will be performed in Houston, Texas. No major subcontractors or set aside designations were indicated. The National Cancer Institute is the federal agency responsible for cancer research within the United...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract is for the production of a supplement to the Journal of the National Cancer Institute (JNCI) Monographs, specifically a 50th anniversary issue of the NCI's Surveillance, Epidemiology, and End Results (SEER) Program. The contract has a ceiling value of $77,580.00 and a...
- The National Cancer Institute (NCI), part of the Department of Health and Human Services, awarded a $244,943 firm fixed-price purchase order contract to the Public Health Institute, a non-profit organization, to conduct the NCI Patterns of Care Study for prostate cancer, ovarian cancer, and small intestines cancer diagnosed in 2021. The contract, which has no set-aside designation, will involve abstracting medical records to describe cancer treatment patterns, compare treatments over time and...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $120,000 firm fixed price purchase order to Cancer Letter Inc., doing business as The Cancer Letter, for an annual institution-wide online subscription to cancer research and drug development content. The subscription provides access for 3,000-4,000 users, with 24/7 access to current and archived cancer-related news, summaries of NCI and FDA grant opportunities and drug approvals, cancer research funding opportunities, and clinical trial information. The base period of performance is from September 21, 2019 to September 20, 2020, with an optional 12-month extension. No set-aside designation was used for this award.
Generated 3/23/24, 11:35 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
The Cancer Letter - Annual Institution-wide Online Subscription to Cancer Research | 75N91019R00035 | Department of Health and Human Services National Institutes of Health National Cancer Institute | Solicitation 1/1 | 8/5/19, 11:51 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $24.0k | 9/14/21 | |
| P00001 | Exercise an Option | $48.0k | 9/14/20 | |
| Not listed | Not listed | $48.0k | 9/19/19 |